Acute pain

The FDA ( U.S. Food and Drug Administration ) has granted accelerated approval to Keytruda ( Pembrolizumab ) for the...


The FDA ( U.S. Food and Drug Administration ) has granted accelerated approval to Tecentriq ( Atezolizumab ) for the...


The Committee for Medicinal Products for Human Use ( CHMP ) has adopted a positive opinion for the medicinal product...


Conflicting blood pressure-lowering effects of catheter-based renal artery denervation have been reported in patients with resistant hypertension. Researchers have compared...


Attacks of neuropathic pain, usually abdominal, are characteristic of the acute porphyrias and accompanied by overproduction of heme-precursor molecules, specifically...


Teva Pharmaceutical has announced the successful completion of its Phase IIb migraine prevention program with positive top-line results from a...


Two separate clinical trials were presented as a part of ACC.15, and looked at strategies to reduce major bleeding and...


Pericarditis is the most common form of pericardial disease and a relatively common cause of chest pain. The objective of...


Ninety-three percent of pediatric patients ( 55 of 59 ) with relapsed/refractory acute lymphoblastic leukemia ( ALL ) went into...


The latest findings from an ongoing phase II study of CTL019, an investigational chimeric antigen receptor T cell ( CART...


A 7-year experience assessing safety and outcomes of Levodopa / Carbidopa intestinal gel infusion ( LCIG ) in 59 advanced...


The Committee for Medicinal Products for Human Use ( CHMP ) of the European Medicines Agency ( EMA ) issued...


The 2015 ESC Guidelines on the diagnosis and management of pericardial diseases are published in European Heart Journal. Previous ESC...


Vitamin D is increasingly recognized for its roles in non-skeletal disorders. Patients with sickle cell disease ( SCD ) have...


A systematic literature study was performed to establish the effects of relaxation therapy on autonomic function, pain, fatigue and daily...


The initial headline conclusions from DIAS-3, the first of two phase III clinical trials of Desmoteplase for the treatment of...


This is an update of a Cochrane review first published in 2006. Gout is one of the most common rheumatic...


Post-thrombotic syndrome ( PTS ) is a common and burdensome complication of deep venous thrombosis ( DVT ). Previous trials...


Vimizim ( Elosulfase alfa ) is the first enzyme replacement therapy ( ERT ) designed to target the underlying cause...


BioMarin has announced that the FDA ( Food and Drug Administration ) has approved Vimizim ( Elosulfase alfa ) for...